(InSilico Medicine, Inc.) The CEO of Insilico Medicine, Alex Zhavoronkov, PhD will present Insilico's latest results in the generation of novel small molecule leads using the Generative Adversarial Networks and Reinforcement Learning, as well as the multi-modal biomarkers of human aging and age-related diseases.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2DcTzpf
No comments:
Post a Comment